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The genotyping of the various isoforms of Apolipoprotein E (apo E) has been performed using matrix-
assisted laser desorption/ionization (MALDI-MS). The polymerase chain reaction was used to amplify the
specific apo E gene sequence followed by digestion with Cfo I (Clostridium formicoaceticum), for generating
restriction fragments for rapid and accurate mass analysis. An exonuclease I digestion step was introduced
to remove the unused primers after PCR, which can otherwise interfere in the mass spectral analysis. By
replacing the gel electrophoresis detection step with MALDI-MS, restriction isotyping of the apo E gene was
achieved. Genotyping of an unknown sample obtained from an independent diagnostic laboratory
demonstrated the validity of the MALDI-MS method for the routine clinical analysis of apo E.# 1998 John
Wiley & Sons, Ltd.
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Apolipoprotein E (apo E) plays an important role in lipid
metabolism and also appears to be involved in cholesterol
transport between different tissues. The apo E gene is
polymorphic, with three common alleles (e2, e3, e4) that
control the expression of six phenotypes, namely, E2/2,
E3/3, E4/4 homozygotes and E2/3, E2/4 and E3/4 hetero-
zygotes. These isoforms differ from each other by a
cysteine–arginine interchange that occurs at one or both of
two positions (112 and 158) in the amino acid sequence.
Apo E3 is the most common isoform (50–70%) in the
general population whereas apo E2 and apo E4 isoforms
typically contribute 8–10% and 10–15%, respectively to the
gene pool.1 Studies have shown that individuals with the
apo E2 isoform have a lower than average cholesterol level,
while those with the E4 isoform have a higher than average
cholesterol level, and may be at a higher risk of developing
atherosclerosis.2
The apo E polymorphism is an important risk factor in the
development of Alzheimer’s and cardiovascular diseases.
Alzheimer’s disease is a complex, heterogeneous, genetic
disorder which involves the degeneration of neurons in the
cerebral vessels causing dementia in the elderly. Thee4
allele has been shown to be associated with increased risk
for the onset of Alzheimer’s disease in many populations
throughout the world.3 Apo E polymorphism is also
associated with Type III hyperlipoproteinemia, a disease
causing the accumulation of triglycerides and cholesterol
rich lipoproteins in the plasma which may contribute to the
development of premature atherosclerosis.4 Studies have
shown a high percentage (90%) of the patients having the
homozygote phenotype E2.
Apolipoprotein E genotyping is a very important
diagnostic test. Apo E polymorphisms have been widely
studied in numerous research laboratories and a number of
methods to type the different isoforms have been developed.
Apo E phenotyping by isoelectric focusing5,6 and two
dimensional gel electrophoresis7,8 are two common meth-
ods of studying the protein. Some of the methods of
genotyping that are being pursued include single strand
conformation polymorphism (SSCP),9 hybridization with
allele specific oligonucleotides (ASO),10,11 restriction
isotyping with specific endonucleases12,13 and sequen-
cing.14 All of these methods involve the amplification of
the apo E genomic sequence containing the common
polymorphic sites. Restriction isotyping is a commonly
accepted method for genotyping of apolipoprotein E. This
method involves the determination of apo E genotype by
exploiting the specificity of a restriction endonuclease for
certain regions of the amplified sequence. A major draw-
back of each of these techniques is the time required for the
detection of the DNA by gel electrophoresis. Other dis-
advantages include the inability to detect small DNA
fragments (40 bp) with ethidium bromide staining.
Acrylamide gels, which are commonly used to detect small
DNA fragments, contain a potential neurotoxin. In addition,
because gel electrophoresis is not easily automated, only a
relatively small number of samples can be analyzed in a
day.13 Hence a rapid, efficient and yet hazard free detection
technique is needed.
In this work, MALDI-MS is used for genotyping of the
apo E gene. MALDI-MS has been shown as a possible
replacement for gel electrophoresis detection in DNA
genetic screening studies. For example, MALDI-MS has
been highly successful as a detection tool in DNA screening
studies of the Tay–Sachs gene,15 CFTR gene16–18and in the
detection of single and two nucleotide mutations in the
L1CAM gene.19,20 MALDI-MS has also been used for the
detection of specific regions of PCR amplified bacterial
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genome in a studyinvolving Legionella species.21 The use
of peptide nucleic acid probes as DNA mimics for the
MALDI-MS typing of human leukocyte antigen(HLA) has
recently beenreportedby Girard andco-workersasa new
MALDI-MS application for genetic screening problems.22
More recently, Little and co-workers have demonstrated
MALDI-MS as a viable technique for detecting apo E
polymorphismsusing PROBE reactions.23 In this proce-
dure,sequencespecificprimersareextendedby a seriesof
basesunique to the identity of a particular allele site,
producing low massproducts for MAL DI-MS detection.
In thispresentwork wedemonstratethatMAL DI-MS can
beusedasaroutinedetection methodin a typicaldiagnostic
lab where restriction isotyping is performed on a regular
basis and the products generated are detected by gel
electrophoresis. Here, the polymerase chain reaction
(PCR) is used to generate the initial sequenceof apo E
genefor our experiments and the molecular weight of the
isolatedandamplified DNA is studied by MALDI-MS. The
amplified genomic DNA is subjected to Exonuclease I
digestion to removeexces primers after the PCRstep that
would otherwise result in saturation effects in the mass
spectrometer. Subsequently, restriction fragment length
polymorphism(RFLP) by a specific endonucleaseis used
to determine theapoE genotype.DNA fragmentsfrom the
digestion were studied by both gel electrophoresis and
MALDI -MS. An unknown sample from an independent
diagnostic laboratorywas also successfully amplified and
digestedby PCR-RFLP and the resulting fragments were
detectedby massspectrometry. Mass spectral data were
confirmed later by gel electrophoresis performedby the
diagnostic lab.
EXPERIMENT AL
Amplificat ion of apo E sequencesfrom genomic DNA
GenomicDNA wasextractedfrom 1 mL wholebloodusing
a commercial ‘salt-extraction’ kit (PuregeneTM, Gentra
SystemsInc. Minneapolis, MN, USA). The final DNA
preparationsweredissolved in 0.33mL of 10mM Tris and
1 mM EDTA buffer(pH 8.0).DNA wasamplified by PCRin
a DNA thermocycler (M. J. Research,Watertown, MA,
USA) usingoligonucleotideprimers that were synthesized
at the DNA synthesis core facility at the University of
Michigan.Theprimer designwasbasedonthosepreviously
reportedfor the PCRamplification of the apoE gene.12,14
Thesequencesof theprimersaswell astheamplified apoE
Figure 1. DNA sequenceof PCRamplifiedapolipoproteinE andthelocationsof Cfo I cleavagesites.Thesequence
of onestrandof the264bp amplifiedproductof thee4 allele is shown,andthevariationsdueto e2 ande3 isoforms
are shownabovethe e4 sequence.: representsthe cut sitesfor the Cfo I restrictionenzymeand the recognized
sequence,GCGC,is underlinedthroughout.Theprimersequencesareshownin bold. Lower caselettersrepresent
basesthat do not appearin theapoE genomicsequence,but wereaddedto theprimersasprimer ‘tails’.12,13
Table 1. The constantand polymorphic restriction sitesfor the Cfo I enzymeand the expectedfragment lengthsafter digestion
ApoE allele Restrictionsequenceandnucleotidepositionfor Cfo I cleavage Fragments,bp
e2 GCGCat positions38, 54, 145,163 18, 38, 91, 101
e2/e3 GCGCat positions38, 54, 145,163,211 18, 38, 48, 53, 91, 101
e2/e4 GCGCat positions38, 54, 73, 145,163,211 18, 19, 38, 48, 53, 72, 91, 101
e3 GCGCat positions38, 54, 145,163,211 18, 38, 48, 53, 91
e3/e4 GCGCat positions38, 54, 73, 145,163,211 18, 19, 38, 48, 53, 72, 91
e4 GCGCat positions38, 54, 73, 145,163,211 18, 19, 38, 48, 53, 72
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geneare shownin Fig. 1. Eachamplification reactionin-
cluded400 ngof genomic DNA, 1X PCRbuffer (supplied
with TaqPolymerase),15mM MgCl2, 200nM eachof sense
andantisenseprimers,10% DMSO,100mM of eachdNTP
and 5 units (5 U/mL) of Taq polymerase(GIBCO-BRL).
Eachreactionmixturewassubjectedto an initial denatura-
tion step at 94°C for 1 min, followed by 39 cycles of
denaturation(45sat94°C),primerannealing (30sat60°C)
an elongation (1 min at 70°C). The amplified DNA were
thensubjectedto a final extensionat 72°C for 5 min. The
amplified sequence was purified from the interfering
enzymesand buffersusingQiagenPCRquickKit (Qiagen
Inc.,Chatsworth, CA, USA),prior to massspectral analysis.
ExonucleaseI digestion of prim ers
Theamplified genomic DNA from variouspatientsamples
were set up for exonucleaseI digestionin a thermocycler
(M. J. Research,Watertown, MA, USA). The protocol
included an initial incubation at 70°C for 10 minutes to
minimizedimerizationof primers.Exonuclease I (4 U) was
addedto eachreactionfollowed by incubationat 37°C for
15minutes.Theenzymewasheatinactivatedby incubating
the mixture for anadditional 10 minutesat 70°C.
Restriction enzymatic digestion of amplified apo E
The amplified apo E sequenceswere then subjected to
restriction enzymatic digestion by the addition of Cfo I
directly to thePCRmixture in thepresenceof 1X restriction
enzyme buffer. Complete digestion was achieved by
incubatingthemixture for 6 hoursat 37°C. Thecut sites
for theCfo I enzymeandtheexpectedfragmentsareshown
in Table1. DNA fragmentslessthan100bp in lengthcould
not be subjected to Qiaquick purification procedures.
Instead, the restriction enzymedigestswere purified by
ethanol precipitation of theDNA. The ethanolprecipitation
protocol involvedmixing thefragmentswith 0.5volumeof
7.5M ammoniumacetateand3 volumesof icecoldethanol.
This mixture wasallowed to standat ÿ75°C overnight to
increasethe recovery of low massDNA fragments. The
DNA fragmentswerepelletedby spinningtheprecipitatesat
Figure 2. Gelelectrophoresisresultof theamplifiedapoE sequenceandtheCfo I fragments.lane1: molecularweightmarker,10bp ladder,lane2:
e2 isoform,lane3: e2/e3 allele,lane4: e2/e4 allele,lane5: e3 isoform,lane6: e3/e4 allele, lane7: e4 isoform,andlane8: 264bp PCRproduct.The
expectedCfo I restrictionfragmentsareshownon the right.
# 1998JohnWiley & Sons,Ltd. Rapid Commun.MassSpectrom.12, 1045–1050(1998)
GENOTYPING OF APOLIPOPROTEIN E BY MALDI-M S 1047
14000rpmfor 30 min at4°C. TheDNA pelletswerethen
thoroughly washedwith 0.5 volume of 70% ethanol and
resuspendedin DNAse free water (2–4mL) for further
MALDI-MS analysis.
Massspectrometric analysis
All MALDI -MS spectrawerecollected on a linear time-of-
flight mass spectrometer(R. M. Jordan Co., GrassValley,
CA, USA) ashasbeendescribed previously.24 Briefly, the
MALDI ionsweregeneratedby a355nmfocusedoutput of
a frequency tripled DCR-11 Nd:YAG laser (Spectra
Physics,Mountainview, CA, USA). The ions formedwere
acceleratedto 40kV andcurrentsignalsweredetectedby an
18mm triple microchannelplatedetector (Jordan)placed1
m from the ion optics. Ion signalswere amplified by the
presence of a CuBe venetian blind conversion dynode
(15kV), but at theexpense of resolution. The ion currents
were measured by a LeCroy 9350M digital oscilloscope
(LeCroy Corporation, Chestnut Ridge,NJ, USA) andpro-
cessedon anIBM Pentiumprocessor.An averageof 30–50
mass spectrawere recorded for each genotype studied.
Pulsed delayed extraction (PDE) was not used for the
spectrapresentedin this work. Theresolution enhancement
dueto PDEwascompromisedby the lossof resolution due
to the post acceleration stage,which was necessary for
improved detection sensitivity. Since resolution is not an
issue in this presentmethodology and higher sensitivity
implied detection of the important restriction enzyme
products, the post acceleration stagewas usedinstead of
the PDE.
The resultspresentedhereinused2 mL of a 3-hydroxy-
picolinic acidandpicolinic acid (3-HPA/PA) (4:1)matrix in
36%acetonitrile, asthematrix for desorption.The matrices
werepurchasedfrom SigmaChemical Co. (St. Louis, MO,
USA) andusedwithout furtherpurification.Thepresenceof
nitrocellulose (Immobilon-LC Pure, Mill ipore, Bedford,
MA, USA) for on-probe ion exchangepurification was
foundto beessentialin obtaining reproduciblemassspectral
data.Nitrocellulose(1–2mL) wascoatedon to thestainless
steelsample probetip asa16mg/mL solutionin acetone.
The precipitated DNA wasredissolved in deionized water
(2–4mL), spottedonto the thin film and allowed to dry
beforethe addition of the 3-HPA/PA matrix mixture. The
entiremixture on the probetip wasallowedto dry at room
temperature before being inserted into the mass spec-
trometer.
Figure 3. MALDI-MS of PCRamplifiedapoE from a 4:1 3-HPA/PA
matrix. Nitrocellulosemembranewasusedfor on-probepurification.
The laserwavelengthusedwas355nm.
Figure 4. MALDI-MS of Cfo I digestedapoE (a) e2, (b) e3 and(c) e4,
isoformsusinga3-HPA/PA(4:1)matrixand355nmlaserwavelength.
Thepresenceof 101bpand91bp,theabsenceof 101bpand72bp,and
the presenceof 72 bp are characteristicof the e2, e3 and e4 alleles
respectively.
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RESULTS AND DISCUSSION
Analysis of amplified apo E gene
Thegenomic DNA samplesfrom patientswereamplified by
polymerasechainreactionto a final lengththatwasdefined
by the specific primers chosen. Figure 1 showsthe PCR
amplified sequenceobtained for thedifferentgenotypes. A
single prominent band at 264bp was seen as the final
product when detectedby gel electrophoresis (Fig. 2).
Figure3 is theMALDI -MS observedfor thePCRamplified
DNA with the single stranded parent ion of the ds DNA
arriving at 184ms.
Restriction isotyping of amplified apo E
The restriction isotyping of apo E is accomplished by
cleaving thePCRproduct with Cfo I in orderto distinguish
thesix isoforms.Figure1 showsthesix cleavagesitesin the
amplified apoE sequence.Therecognitionsequencefor the
Cfo I enzymeis GCGCwhich is presentat four constantand
two polymorphic sites in the apo E sequence.The e4
sequenceis presentedin thefigurealong with thenucleotide
variations presentin the e2 and e3 forms. The e2 isoform
differs from the e4 dueto a thymine substitution at nucleo-
tide positions71 and211,thuseliminating the two enzyme
cleavagesites (from GCGC to GTGC). The e3 isoform
producesfive Cfo I cleavagesitesby maintainingtheGCGC
sequenceat position211but removing thepolymorphic site
at position71.Theresulting fragmentpatternsobservedfor
the six isoforms of apo E are shownin Table 1. The gel
electrophoresis results obtained for theCfo I cleavedDNA
samples representing thedifferenthomozygousandhetero-
zygouscombinationsof apoE areshown in Fig. 2.
A primer digestion step was used before restriction
enzyme digestionsincethe presenceof oneof the primers
(46mer) causedoccasional interferencein detection of the
higher massfragments. In addition, the absence of the 46-
merprimer simplifies thespectrain theregionof the48bp
diagnostic fragment. The primers were digested using
Exonuclease I which is an exodeoxyribonuclease that
digests single-stranded(ss) DNA in a 3' to 5' direction.
This procedure was performed after the PCR step, but
beforethe restriction enzymewasadded.
Figure 4(a)is theMALDI mass spectrumobtainedfor an
e2 homozygote. The e2 allele is characterized by the
presenceof the91bpand101bp fragmentsandtheabsence
of the 48bp, the 53bp andthe 72bp fragments. The 18bp
and the 38bp peaksare commonto all the apo E allele
combinationsandarenot generally detectedby gel electro-
phoresisdueto their small size.
The91bp andthe101bp fragmentsresult from cleavage
at all four of the constant Cfo I sites but none of the
polymorphic sites.
The e3 allele is recognizedby the presenceof the 91bp,
53bp and48bp fragments(Fig. 4(b)). The 91bp fragment
reflects theabsenceof acutsitecontributedby themutation
occurring at nucleotide position 71. The 48bp and 53bp
fragmentsresultfrom thepolymorphic Cfo I siteat position
211, therebyeliminating the 101bp fragmentobserved in
the e2 allele.
In comparison,Fig.4(c)representstheMALDI-MS of the
PCR products from an e4 homozygote. This pattern is
characterized by the72bp fragmentwhich resultsfrom the
cleavageat nucleotide position 71. The other fragment
generateddueto thesamemutation is 19bp in length but is
not typically useddiagnostically dueto its proximity to the
18bpconstant-sitefragment.Thee4 allelealso producesthe
48bp andthe 53bp fragments. The peakarriving at 53ms
belongsto oneof theprimers(25mer)andis mostlikely due
to incomplete ExonucleaseI digestion. The heterozygotic
combinationsthat containedone of eachallele resulted in
threedifferent combinationswhich werealso studied using
MALDI-MS. The resultsof the MAL DI-MS typing of the
e2/e3, e2/e4 ande3/e4 samples areshownin Fig. 5.
A test for the successof the MAL DI-MS technique
described aboveinvolved the determination of the apo E
genotype of an unknown DNA sample. A sample of
genomic DNA wasobtained from the MolecularDiagnos-
tics Laboratory, University of Michigan Medical Center,
where apoE genotyping is performedon a routinebasisby
PCR-RFLP followed by gel electrophoresis detection.
Figure 5. (a) MALDI-MS of Cfo I digestedapoE (a)e2/e3, (b) e2/e4
and(c) e3/e4 allelesusinga 3-HPA/PA(4:1) matrix and355nm laser
wavelength.
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Figure6 is theMALDI-MS of theunknownDNA. Themass
spectrum is characterized by the 91bp, 53bp and 48bp
fragmentswhich clearly indicatesthat this patientis an e3
genotype. The massspectral resultswere later confirmed
with thegel electrophoresisdataobtainedby theMolecular
Diagnostics Lab.
CONCLUSIONS
We havedemonstratedtheuseof MALDI-MS asa clinical
diagnostic tool for genotyping the apolipoprotein E gene.
By replacing thestandard gel electrophoresistechnique for
detection of the restriction isotyped fragments, we have
shown the feasibility of MALDI -MS for studying double
stranded DNA productsgenerated for diagnostic purposes.
The ability of MALDI-M S to genotype unknown DNA
sampleshasalsobeendemonstrated.
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